Team

We have gathered a very experienced
and motivated team of managers and external advisors

  • Adam Kruszewski

    MD, MBA
    Chief Executive Officer
  • Artur Płonowski

    MD, PhD
    Chief Medical Officer
  • Jarosław Leszczyszyn

    MD, PhD, MBA
    Chief Scientific Officer
  • Wojciech Tomikowski

    MSc
    Chief M&A Officer
  • Karolina Nowak

    PharmD, PhD, MBA
  • Artur Brus

    MA MSc LLM
    Chief Legal Officer
    • Adam Kruszewski, MD, MBA

      Chief Executive Officer

      Warsaw, Poland, MD, MBA

      Chief Executive Officer
      20+ years of international experience (pharma, health care sector, PE, VC)
      C- level executive with track record of successful turnarounds (Luxmed (Bupa Group), Medicover $1B, Medycyna Rodzinna)
      Built/sold own international business KCR, a leading CRO in the region
      Set up influential health care think tank (CEE HPN)
      Advisor and investor in unicorn Doc Planner

    • Artur Płonowski, MD, PhD

      Chief Medical Officer

      Cupertino, CA, USA, MD, PhD

      20+ years of drug discovery and development in biotech and global pharma industry – Exelixis, Takeda, Akarna, Allergan
      Co-founder of US companies (Seal Rock Therapeutics and Vasa Therapeutics)
      Hands-on experience in project value creation through selection of the most efficient strategies to demonstrate clinical safety and efficacy.
      Track record of successful exits transactions with big pharma

    • Jarosław Leszczyszyn, MD, PhD, MBA

      Chief Scientific Officer

      Warsaw, Poland/ Dublin, Ireland, MD, PhD, MBA

      Entrepreneur, hospital and outpatient medical business ( EMC IM SA, EMC HC Ltd ( Ireland), PSMS Ltd (Ireland)
      Co-founder/former deputy CEO EMC Instytut Medyczny SA( public listed company-private hospitals network)
      Former professor of gastroenterology, National Institute for Rheumatology and Rehabilitation, Warsaw
      25 years of experience in more than 50 clinical trials as PI and national coordinator (autoimmune diseases, gastroenterology, pain medicine, oncology, infectious diseases)

    • Wojciech Tomikowski, MSc

      Chief M&A Officer

      Warsaw, Poland, MSc

      20y+ experience/ C- level executive e.g. in Novartis Consumer Health
      General Management international experience in turnarounds/bd/M&A (South America, China, Russia and Europe)
      Partner in PE/VC, owner of a M&A advisory boutique
      Executive education programs at HBS, Wharton, LBS

    • Karolina Nowak, PharmD, PhD, MBA

      10 + years of international experience (R&D, Academia)
      Visiting scientist at Harvard Medical School, Department of Genetics, Dana-Farber Cancer Institute
      Internship at Stanford Biomaterials and Advanced Drug Delivery Laboratory
      Alumni of Top 500 Innovators at Stanford University
      Alumni of Executive MBA, ESG University of Quebec at Montreal
      Patent owner and active scientist

    • Artur Brus, MA MSc LLM

      Chief Legal Officer

      Warsaw, Poland, MA MSc LLM

      Vice President at Citibank
      Co-founder of Clinical Servant, which is developing Smart Container for Clinical Trials (SCCT)
      A graduate of the University of Cambridge and the University of Copenhagen
      Completed the ‘From Idea to Health Business Programme’ at Imperial College Business School

    3

    Scientific Board

    • Leszek Lisowski

      PhD, MBA
      Scientific
      • Leszek Lisowski, PhD, MBA

        Scientific

        Sydney, Australia, PhD, MBA

        Founder of LogicBio, a Nasdaq listed $ 0.5B company
        Associate professor University of Sydney, Children’s Medical Research Institute (CMRI) in Australia
        Expert in viral gene therapy, vectorology and genotoxicity (developed novel lentiviral and AAV vectors)
        Established a Vector and Genome Engineering Facility at CMRI

      3

      Business Advisory

      • Tomasz Rejman


        Strategy, Business Development
      • Łukasz Olek

        MEng
        Technology
      • Piotr Hammer

        MD
        Scientific
        • Tomasz Rejman,

          Strategy, Business Development

          Warsaw, Poland,

          SVP of McKinsey Restructuring in London
          Lead improvement projects for main Polish Oncological Centers
          Former COO of Allianz Poland, Cersanit (consumer goods) and PKN ORLEN (chemicals)
          30 years of C-level experience in business development, turnaround/ restructuring and performance improvement across a variety of industries and continents

        • Łukasz Olek, MEng

          Technology

          Warsaw, Poland, MEng

          Advisor – investor and entrepreneur with IT background with over 10 years of experience
          In 2010 co-founded and managed first online currency exchange business in Poland (internetowykantor.pl and walutomat.pl) that grew up to 100 people and 1B PLN monthly turnover. Successfully exited in 2017
          Since 2017 investor and advisor in multiple technology startups

        • Piotr Hammer, MD

          Scientific

          Łódź, Poland, MD

          Active participant in the medical market in Poland since 1991
          CEO & Founder (2002) of HammerMed Medical Polska Ltd LLP (one of the leading supplier of medical devices in Poland)
          CEO & Founder (2009) of HammerMed II Nieruchomosci Ltd LLP
          Expert in introducing minimal invasive devices into the market
          Co-author of articles on the treatment of thoraco-abdominal aneurysms

        3